Regione Lombardia
15
2
2
8
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
6.7%
1 terminated/withdrawn out of 15 trials
88.9%
+2.4% vs industry average
20%
3 trials in Phase 3/4
0%
0 of 8 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (15)
Big Data for Quality of Life in Head and Neck Cancer
Role: collaborator
MYTHS - MYocarditis THerapy With Steroids
Role: collaborator
Artificial Intelligence - SARS-CoV-2 (COVID-19) Risk Evaluation
Role: collaborator
Cost-effectiveness Analysis of an Antimicrobial Stewardship Program in Regione Lombardia (RF-net2018)
Role: collaborator
Multidisciplinary Approach for Poor Prognosis Sinonasal Tumors in Inoperable Patients
Role: collaborator
Multidisciplinary Approach for Poor Prognosis Sinonasal Tumors in Operable Patients
Role: collaborator
Experimentation of an Ankle Mobilization Device for the Rehabilitation of Patients With Acquired Brain Injuries.
Role: collaborator
Low-Tox Vs Eox In Patients With Locally Advanced Unresectable Or Metastatic Gastric Cancer
Role: collaborator
Maintenance Low Dose Oral Navelbine In Patients With Non Small Cell Lung Cancer - MA.NI.LA Trial
Role: collaborator
Trial of Pentostatin Plus Cyclophosphamide With Ofatumumab (PCO) in Older Patients With Chronic Lymphocytic Leukemia
Role: collaborator
Second Line Therapy in Advanced Biliary Tract Cancer
Role: collaborator
Transplanted-like Heart in Critical Ill Patients
Role: collaborator
Prognostic Factors for Patients With Advanced Colorectal Cancer Treated With Cetuximab.
Role: lead
Evolution of Management Strategies of Heart Failure Patients With Implantable Defibrillators
Role: lead
Trastuzumab Optimization Trial in Breast Cancer
Role: lead
All 15 trials loaded